Moderna (MRNA) and CytomX (CTMX) Enter Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics
Go back to Moderna (MRNA) and CytomX (CTMX) Enter Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 3.75 +0.01 (0.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.74 | 52 Week High | $24.68 | |||
| Open | $3.75 | 52 Week Low | $9.10 | |||
| Day High | $3.89 | P/E | N/A | |||
| Day Low | $3.64 | EPS | $0.00 | |||
| Volume | 5,925,389 | |||||
| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 70.03 +0.33 (0.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $69.70 | 52 Week High | $0.52 | |||
| Open | $69.83 | 52 Week Low | $0.08 | |||
| Day High | $73.28 | P/E | N/A | |||
| Day Low | $69.22 | EPS | $-3.80 | |||
| Volume | 11,804,221 | |||||

